Jokubaitis, Vilija G.
Zhou, Yuan
Butzkueven, Helmut
Taylor, Bruce V.
Article History
First Online: 24 April 2018
Compliance with Ethical Standards
:
: Vilija G. Jokubaitis, Yuan Zhou, and Bruce V. Taylor declare no conflict of interest.Helmut Butzkueven is on the Australian advisory board and Global Advisory boards for Novartis, Biogen, Merck, and Teva, and is a consultant for Novartis (Progressive MS consultancy) and Oxford Pharmagenesis (MS Brain Health Steering Committee). Dr. Butzkueven reports research grants from Biogen and Novartis and lecture fees paid to him from Biogen. Dr. Butzkueven has received payment for the development of educational presentations for Biogen (MS Atlas Meetings), Novartis (National MS workshop), and Merck (Global Registries workshop).
: This article does not contain any studies with human or animal subjects performed by any of the authors.